Atlas Wealth LLC Pfizer Inc Transaction History

Atlas Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $411,522 - $481,028	-12,824 Reduced 33.89%	25,018 $830 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $488,739 - $565,460	-13,531 Reduced 26.34%	37,842 $1.37 Billion
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $343,717 - $447,469	-8,726 Reduced 14.52%	51,373 $2.1 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $2.51 Million - $3.28 Million	60,099 New	60,099 $3.08 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Atlas Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Wealth LLC with notifications on news.